On the public citation graph
Sabadinine: A Potential Non-Peptide Anti-Severe Acute-Respiratory-Syndrome Agent Identified Using Structure-Aided Design
0 signed · 44 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1007/bf00124499openalex-snapshot
Distributed automated docking of flexible ligands to proteins: Parallel applications of AutoDock 2.4
inferredcites →https://doi.org/10.1016/s0140-6736(03)13410-1openalex-snapshot
Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong
inferredcites →https://doi.org/10.1056/nejmoa030747openalex-snapshot
Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome
inferredcites →https://doi.org/10.1089/088282403771926292openalex-snapshot
SARS: Lessons Learned from Other Coronaviruses
inferredcites →https://doi.org/10.1126/science.1085658openalex-snapshot
Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS Drugs
inferredcites →https://doi.org/10.1128/jvi.77.8.4972-4978.2003openalex-snapshot
Murine Coronavirus-Induced Hepatitis: JHM Genetic Background Eliminates A59 Spike-Determined Hepatotropism
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/chin.200428222openalex-snapshot
Sabadinine: A Potential Non‐Peptide anti‐Severe Acute‐Respiratory‐Syndrome Agent Identified Using Structure‐Aided Design.
inferred← citeshttps://doi.org/10.1002/ptr.6887openalex-snapshot
A role for quercetin in coronavirus disease 2019 (COVID‐19)
inferred← citeshttps://doi.org/10.1007/978-3-7643-8117-2_6openalex-snapshot
Virtual screening for the discovery of bioactive natural products
inferred← citeshttps://doi.org/10.1007/s00210-023-02517-2openalex-snapshot
Role of phytocompounds as the potential anti-viral agent: an overview
inferred← citeshttps://doi.org/10.1016/j.bbrc.2004.06.155openalex-snapshot
“Teaching old drugs to kill new bugs”: structure-based discovery of anti-SARS drugs
inferred← citeshttps://doi.org/10.1016/j.bbrc.2004.07.003openalex-snapshot
Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A
inferred← citeshttps://doi.org/10.1016/j.bbrc.2005.11.102openalex-snapshot
The N-terminal octapeptide acts as a dimerization inhibitor of SARS coronavirus 3C-like proteinase
inferred← citeshttps://doi.org/10.1016/j.bmcl.2004.06.083openalex-snapshot
2-Substituted benzoxazinone analogues as anti-human coronavirus (anti-HCoV) and ICAM-1 expression inhibition agents
inferred← citeshttps://doi.org/10.1016/j.bmcl.2005.04.027openalex-snapshot
Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors
inferred← citeshttps://doi.org/10.1016/j.bmcl.2005.09.012openalex-snapshot
Screening of electrophilic compounds yields an aziridinyl peptide as new active-site directed SARS-CoV main protease inhibitor
inferred← citeshttps://doi.org/10.1016/j.bmcl.2005.11.018openalex-snapshot
From genome to drug lead: Identification of a small-molecule inhibitor of the SARS virus
inferred← citeshttps://doi.org/10.1016/j.chembiol.2004.08.011openalex-snapshot
High-Throughput Screening Identifies Inhibitors of the SARS Coronavirus Main Proteinase
inferred← citeshttps://doi.org/10.1016/j.febslet.2004.09.026openalex-snapshot
Characterization of SARS‐CoV main protease and identification of biologically active small molecule inhibitors using a continuous fluorescence‐based assay
inferred← citeshttps://doi.org/10.1016/j.tet.2020.131761openalex-snapshot
Advances in developing small molecule SARS 3CLpro inhibitors as potential remedy for corona virus infection
inferred← citeshttps://doi.org/10.1016/j.virusres.2020.197989openalex-snapshot
Natural product-derived phytochemicals as potential agents against coronaviruses: A review
inferred← citeshttps://doi.org/10.1016/j.ygeno.2020.07.033openalex-snapshot
Genomics approaches to synthesize plant-based biomolecules for therapeutic applications to combat SARS-CoV-2
inferred← citeshttps://doi.org/10.1021/ci049809bopenalex-snapshot
Virtual Screening of Novel Noncovalent Inhibitors for SARS-CoV 3C-like Proteinase
inferred← citeshttps://doi.org/10.1021/jm0501782openalex-snapshot
A New Lead for Nonpeptidic Active-Site-Directed Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus Main Protease Discovered by a Combination of Screening and Docking Methods
inferred← citeshttps://doi.org/10.1021/jm050852fopenalex-snapshot
Discovery of a Novel Family of SARS-CoV Protease Inhibitors by Virtual Screening and 3D-QSAR Studies
inferred← citeshttps://doi.org/10.1021/jm060207oopenalex-snapshot
Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Main Protease
inferred← citeshttps://doi.org/10.1039/c1sc00152copenalex-snapshot
Molecular docking for virtual screening of natural product databases
inferred← citeshttps://doi.org/10.1517/13543776.17.5.533openalex-snapshot
Pharmacophores and biological activities of severe acute respiratory syndrome viral protease inhibitors
inferred← citeshttps://doi.org/10.18231/j.ijmmtd.2022.022openalex-snapshot
Review on molecular docking analysis of herbal compounds and their activity against SARS and JEV using In-silico and In vitro approaches
inferred← citeshttps://doi.org/10.2174/138161206779010369openalex-snapshot
Drug Design Targeting the Main Protease, the Achilles Heel of Coronaviruses
inferred← citeshttps://doi.org/10.2174/138161206779010459openalex-snapshot
An Overall Picture of SARS Coronavirus (SARS-CoV) Genome-Encoded Major Proteins: Structures, Functions and Drug Development
inferred← citeshttps://doi.org/10.2174/1389557521666210805113231openalex-snapshot
Nature-Derived Hit, Lead, and Drug-Like Small Molecules: Current Status and Future Aspects Against Key Target Proteins of Coronaviruses
inferred← citeshttps://doi.org/10.2174/1568026620666201207095626openalex-snapshot
Docking Paradigm in Drug Design
inferred← citeshttps://doi.org/10.2174/187152609787847659openalex-snapshot
Drug Targets in Severe Acute Respiratory Syndrome (SARS) Virus and other Coronavirus Infections
inferred← citeshttps://doi.org/10.2174/2210315512666220613101120openalex-snapshot
Herbal Therapeutics as Potential Prophylaxis for SARS-CoV-2 Infection
inferred← citeshttps://doi.org/10.3389/fcimb.2022.929430openalex-snapshot
In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective
inferred← citeshttps://doi.org/10.3389/fphar.2020.589044openalex-snapshot
A Review on Plant Bioactive Compounds and Their Modes of Action Against Coronavirus Infection
inferred← citeshttps://doi.org/10.3389/fphar.2021.590509openalex-snapshot
Anti–SARS-CoV-2 Natural Products as Potentially Therapeutic Agents
inferred← citeshttps://doi.org/10.3389/fvets.2020.573159openalex-snapshot
Phytogenic Products and Phytochemicals as a Candidate Strategy to Improve Tolerance to Coronavirus
inferred← citeshttps://doi.org/10.4018/978-1-7998-7258-0.ch004openalex-snapshot
Quercetin for the Experimental Treatment of COVID-19
inferred← citeshttps://doi.org/10.52711/0974-360x.2024.00650openalex-snapshot
Exploring the Potential of Bioactive Metabolites in COVID-19 Management through main Protease Enzyme (MPRO) Inhibition
inferred← citeshttps://doi.org/10.5897/ajmr11.590openalex-snapshot
Interaction of severe acute respiratory syndrome (SARS) nucleocapsid protein with macrophage migration inhibitory factor protein (MIF)
inferred← citeshttps://doi.org/10.61186/sjku.29.5.11openalex-snapshot
A review on phytogenic compounds inhibit coronaviruses associated with respiratory syndrome in human
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.